Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Depreciation & Amortization (CF) (2016 - 2025)

OptimizeRx's Depreciation & Amortization (CF) history spans 16 years, with the latest figure at $1.1 million for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) fell 1.28% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $4.3 million, up 2.38%, while the annual FY2024 figure was $4.3 million, 80.22% up from the prior year.
  • Depreciation & Amortization (CF) for Q3 2025 was $1.1 million at OptimizeRx, up from $1.1 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.1 million in Q3 2024 and bottomed at $385152.0 in Q4 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $578116.0 (2022), against an average of $759600.9.
  • The largest annual shift saw Depreciation & Amortization (CF) decreased 19.57% in 2023 before it surged 134.98% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $385152.0 in 2021, then rose by 18.54% to $456545.0 in 2022, then soared by 120.57% to $1.0 million in 2023, then rose by 8.64% to $1.1 million in 2024, then decreased by 1.19% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Depreciation & Amortization (CF) are $1.1 million (Q3 2025), $1.1 million (Q2 2025), and $1.1 million (Q1 2025).